Almirall and IRB Barcelona collaborate on molecular glue degraders for skin diseases Jan. 19, 2022 No Comments
TOPADUR Pharma identifies dual PDE5A inhibitors/soluble guanylate cyclase activators Dec. 29, 2021 No Comments
Researchers publish preclinical data on dimeric peptides as hair growth stimulants for alopecia Dec. 27, 2021 No Comments
Ichnos grants Almirall global rights to develop and commercialize ISB-880 for autoimmune diseases Dec. 14, 2021 No Comments
RSS